Viewing Study NCT04447027


Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2026-05-28 @ 8:23 AM
Study NCT ID: NCT04447027
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-01
First Post: 2020-06-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
Sponsor:
Organization: